PTEN and glioblastoma: In the tumor’s infiltrative zones, PTEN-deficient GBM cells secrete increased levels of C-C Motif Chemokine Ligand 2 (CCL2), facilitating the recruitment of myeloid cells, thereby promoting tumor growth and suppressing immune activity [88].